Review of vaccine effectiveness assumptions used in economic evaluations of infant pneumococcal conjugate vaccine
出版年份 2017 全文链接
标题
Review of vaccine effectiveness assumptions used in economic evaluations of infant pneumococcal conjugate vaccine
作者
关键词
-
出版物
Expert Review of Vaccines
Volume -, Issue -, Pages 1-8
出版商
Informa UK Limited
发表日期
2017-11-23
DOI
10.1080/14760584.2018.1409116
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Impact of protein D-containing pneumococcal conjugate vaccines on non-typeable Haemophilus influenzae acute otitis media and carriage
- (2017) Christopher Clarke et al. Expert Review of Vaccines
- Streptococcus pneumoniae serotype 19A: worldwide epidemiology
- (2017) Raul Isturiz et al. Expert Review of Vaccines
- Direct and Indirect Effectiveness of the 10-Valent Pneumococcal Conjugate Vaccine Against Carriage in a Cluster Randomized Trial
- (2017) Arto A. Palmu et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Surveillance of impact of PCV-10 vaccine on pneumococcal meningitis in Mozambique, 2013 – 2015
- (2017) Aquino Albino Nhantumbo et al. PLoS One
- Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis
- (2017) Tinevimbo Shiri et al. Lancet Global Health
- Direct and indirect impact of 10-valent pneumococcal conjugate vaccine introduction on pneumonia hospitalizations and economic burden in all age-groups in Brazil: A time-series analysis
- (2017) Ana Lucia Andrade et al. PLoS One
- Prevention of early episodes of otitis media by pneumococcal vaccines might reduce progression to complex disease
- (2016) Ron Dagan et al. LANCET INFECTIOUS DISEASES
- Cost Effectiveness of Pneumococcal Vaccination in Children in Low- and Middle-Income Countries: A Systematic Review
- (2016) Surasak Saokaew et al. PHARMACOECONOMICS
- Pneumococcal vaccine impact on otitis media microbiology: A New Zealand cohort study before and after the introduction of PHiD-CV10 vaccine
- (2016) Emma J. Best et al. VACCINE
- Vaccine effectiveness of PCV13 in a 3 + 1 vaccination schedule
- (2016) Raphael Weinberger et al. VACCINE
- Cost-effectiveness analysis of routine pneumococcal vaccination in the UK: a comparison of the PHiD-CV vaccine and the PCV-13 vaccine using a Markov model
- (2016) Emmanuelle Delgleize et al. BMJ Open
- Evaluating the impact of PCV-10 on invasive pneumococcal disease in Brazil: A time-series analysis
- (2016) Ana Lucia Andrade et al. Human Vaccines & Immunotherapeutics
- Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study
- (2016) Matthew R Moore et al. Lancet Respiratory Medicine
- Effectiveness of the 10-Valent Pneumococcal NontypeableHaemophilus influenzaeProtein D–Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media—A Double-Blind Randomized Clinical Trial in Finland
- (2016) Timo Vesikari et al. Journal of the Pediatric Infectious Diseases Society
- Effectiveness of Pneumococcal Conjugate Vaccines (PCV7 and PCV13) against Invasive Pneumococcal Disease among Children under Two Years of Age in Germany
- (2016) Mark van der Linden et al. PLoS One
- Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine
- (2015) Amanda Jane Leach et al. BMC Pediatrics
- Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study
- (2015) Pauline A Waight et al. LANCET INFECTIOUS DISEASES
- Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance
- (2015) Matthew R Moore et al. LANCET INFECTIOUS DISEASES
- Impact of PCV7/PCV13 introduction on community-acquired alveolar pneumonia in children
- (2015) David Greenberg et al. VACCINE
- Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001–2012
- (2015) A. Lepoutre et al. VACCINE
- Choosing between 7-, 10- and 13-valent pneumococcal conjugate vaccines in childhood: A review of economic evaluations (2006–2014)
- (2015) David Bin-Chia Wu et al. VACCINE
- The Health And Medical Care Costs For Hospitalized All-Cause Pneumonia Among Children
- (2015) A Berglund et al. VALUE IN HEALTH
- Impact of Ten-Valent Pneumococcal Conjugate Vaccination on Invasive Pneumococcal Disease in Finnish Children – A Population-Based Study
- (2015) Jukka Jokinen et al. PLoS One
- Do Pneumococcal Conjugate Vaccines Represent Good Value for Money in a Lower-Middle Income Country? A Cost-Utility Analysis in the Philippines
- (2015) Manuel Alexander Haasis et al. PLoS One
- Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants
- (2015) Alienke J. Wijmenga-Monsuur et al. PLoS One
- Impact of 13-Valent Pneumococcal Conjugate Vaccination in Invasive Pneumococcal Disease Incidence and Mortality
- (2014) Zitta Barrella Harboe et al. CLINICAL INFECTIOUS DISEASES
- Efficacy of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus That of 7-Valent PCV (PCV7) Against Nasopharyngeal Colonization of Antibiotic-NonsusceptibleStreptococcus pneumoniae
- (2014) Ron Dagan et al. JOURNAL OF INFECTIOUS DISEASES
- Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study
- (2014) Nick J Andrews et al. LANCET INFECTIOUS DISEASES
- Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children
- (2014) Shalom Ben-Shimol et al. VACCINE
- Efficacy of Pneumococcal Nontypable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) in Young Latin American Children: A Double-Blind Randomized Controlled Trial
- (2014) Miguel W. Tregnaghi et al. PLOS MEDICINE
- Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis
- (2014) Lone Simonsen et al. Lancet Respiratory Medicine
- Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study
- (2014) Carla Magda Allan S Domingues et al. Lancet Respiratory Medicine
- Cost-Effectiveness of a 10- Versus 13-Valent Pneumococcal Conjugate Vaccine in Denmark and Sweden
- (2013) Rogier M. Klok et al. CLINICAL THERAPEUTICS
- Global burden of childhood pneumonia and diarrhoea
- (2013) Christa L Fischer Walker et al. LANCET
- U.S. Hospitalizations for Pneumonia after a Decade of Pneumococcal Vaccination
- (2013) Marie R. Griffin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost-utility analysis of 10- and 13-valent pneumococcal conjugate vaccines: Protection at what price in the Thai context?
- (2013) Wantanee Kulpeng et al. VACCINE
- Serotype prevalence and antibiotic resistance in Streptococcus pneumoniae clinical isolates among global populations
- (2013) M. Hackel et al. VACCINE
- Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway
- (2013) Anneke Steens et al. VACCINE
- Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada
- (2012) Stephanie R Earnshaw et al. BMC INFECTIOUS DISEASES
- Acute Otitis Media Replacement and Recurrence in the Finnish Otitis Media Vaccine Trial
- (2012) J. Jokinen et al. CLINICAL INFECTIOUS DISEASES
- Effects of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D-Conjugate Vaccine on Nasopharyngeal Bacterial Colonization in Young Children: A Randomized Controlled Trial
- (2012) M. R. van den Bergh et al. CLINICAL INFECTIOUS DISEASES
- Comparing Health Outcomes and Costs of General Vaccination with Pneumococcal Conjugate Vaccines in Sweden: A Markov Model
- (2012) Åsa By et al. CLINICAL THERAPEUTICS
- Cost–effectiveness models of pneumococcal conjugate vaccines: variability and impact of modeling assumptions
- (2012) Raymond A Farkouh et al. Expert Review of Vaccines
- Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial
- (2012) Arto A Palmu et al. LANCET
- The cost-effectiveness of a 13-valent pneumococcal conjugate vaccination for infants in England
- (2012) Albert Jan van Hoek et al. VACCINE
- Cost-Effectiveness Analysis of Pneumococcal Conjugate Vaccine in Taiwan: A Transmission Dynamic Modeling Approach
- (2012) David Bin-Chia Wu et al. VALUE IN HEALTH
- Cost-effectiveness of 13-valent pneumococcal conjugate vaccine: Germany, Greece, and The Netherlands
- (2011) David R. Strutton et al. JOURNAL OF INFECTION
- The Impact of the Heptavalent Pneumococcal Conjugate Vaccine on the Epidemiology of Acute Otitis Media Complicated by Otorrhea
- (2011) Kostantinos Stamboulidis et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: Comparing estimates for 7-valent, 10-valent, and 13-valent vaccines
- (2011) Karen Richards Tyo et al. VACCINE
- Evaluación Económica de un Programa de Inmunización Infantil en México Basado en la Vacuna Neumocócica Conjugada 13-Valente
- (2011) Emilio Muciño-Ortega et al. VALUE IN HEALTH
- Health and economic impact of PHiD-CV in Canada and the UK: a Markov modelling exercise
- (2011) Gerhart Knerer et al. JOURNAL OF MEDICAL ECONOMICS
- Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
- (2010) Alessia Melegaro et al. BMC INFECTIOUS DISEASES
- Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A?
- (2010) William P Hausdorff et al. BMC Pediatrics
- Immunogenicity and Reactogenicity of a 13-Valent-pneumococcal Conjugate Vaccine Administered at 2, 4, and 12 Months of Age
- (2010) Matthew D. Snape et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Outcomes and costs associated with PHiD-CV, a new protein D conjugate pneumococcal vaccine, in four countries
- (2010) Sandra E. Talbird et al. VACCINE
- Public health and economic impact of the 13-valent pneumococcal conjugate vaccine (PCV13) in the United States
- (2010) Jaime L. Rubin et al. VACCINE
- Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany
- (2010) Dorothee M. Kieninger et al. VACCINE
- Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae
- (2009) R. Dagan CLINICAL MICROBIOLOGY AND INFECTION
- Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
- (2009) Tamara Pilishvili et al. JOURNAL OF INFECTIOUS DISEASES
- Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of age
- (2009) Roman Prymula et al. VACCINE
- Pneumococcal conjugated vaccines: impact of PCV-7 and new achievements in the postvaccine era
- (2008) Ener Cagri Dinleyici et al. Expert Review of Vaccines
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More